Solutions
By Role

Finance

Market Access/Commercial

Operations

By Stage

First-Time Pharma Commercialization Launch Strategy for Success

Managing In Line Products

Portfolio Growth & Expansion
Solutions

From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.

Solutions overview
Products
Contracts & Pricing

Government Pricing

Rebate Management

Chargeback Management

Script Management

Gross-To-Net

GTN Forecasting

GTN Accruals

GTN Analytics

Platform

ICyte Platform

Channel

Inventory Analytics

Distribution Contract Management

Order Management

Channel Data Solutions

Patient Access

Patient Data Solutions

Patient Analytics

Commercial Data Solutions
Products

IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.

View all products
Services
Regulatory, Compliance & Controls

Finance and GTN Optimization

Policy, Pricing & Reimbursement

Market Access & Payer Strategy

Product and Launch Strategy

Provider & Pharmacy

Patient Access & Affordability

Distribution & Supply Chain

Data & Technology
Consulting & Advisory Services

IntegriChain delivers expert policy, pricing, reimbursement, and regulatory guidance, alongside best-in-class commercialization strategies. We empower pharma companies, from startups to large enterprises, to build efficient access, affordability, and distribution strategies that maximize net revenue.

Learn More
About Us
About Us

Our Leadership

Contact Us

Resources

Blog

News

Events
About Us

We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.

Learn more about our company
Careers
Careers Overview

Mission & Values

IntegriChainer Life in the US

IntegriChainer Life in Pune

Career Openings

Connect with Us
Careers

Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.

Careers overview
Search
Let’s Talk

Blog

Category: All Blog Posts

Posts for tag: 340B

Contracts & Pricing Olivia Nweze

February 24, 2022

Branded Pharma Fee: Manufacturer Considerations

5 Minute Read

And other regulatory updates on Line Extension guidance, the upcoming DUNS number transition, and emergency 340B flexibilities.

Contracts & Pricing Gourab Khan

January 24, 2022

New Year, New Laws: Drug Price Reform, Coverage Gap, and 340B

4 Minute Read

Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.

Distribution Dave Weiss

September 26, 2018

Frequently Asked Questions – 340B Program

4 Minute Read

The 340B program is subject to increasing scrutiny as pharmaceutical manufacturers search for solutions to identify and act on non-compliance such as diversion and duplicate discounts. This post is...